Multiple System Atrophy (MSA) is a progressive neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. The autonomic nervous system is profoundly affected, with degeneration of preganglionic autonomic neurons being a hallmark of the disease 1.
MSA affects multiple components of the autonomic nervous system:
- Preganglionic sympathetic neurons: Located in the intermediolateral cell column of the spinal cord
- Preganglionic parasympathetic neurons: Located in brainstem nuclei
- Postganglionic neurons: Sympathetic and parasympathetic target organ innervation
Higher autonomic centers are also affected:
- Hypothalamic neurons: Regulate homeostasis
- Brainstem autonomic nuclei: Dorsal motor nucleus of the vagus, nucleus tractus solitarius
- Spinal autonomic neurons: Intermediolateral cell column
MSA is classified as an α-synucleinopathy with distinctive features:
- Glial cytoplasmic inclusions (GCIs): Hallmark pathology in oligodendrocytes
- Neuronal cytoplasmic inclusions: Affect specific neuronal populations
- Neuronal nuclear inclusions: Less common but present
Autonomic neuronal loss in MSA follows a characteristic pattern:
- Preferential involvement: Preganglionic autonomic neurons
- Regional specificity: Brainstem and spinal cord regions
- Progressive degeneration: Correlates with disease duration
The pathogenesis involves:
- Native protein misfolding: α-synuclein adopts β-sheet conformation
- Oligomer formation: Toxic soluble oligomers accumulate
- Fibril propagation: Spreads throughout connected networks
- Cellular toxicity: Membrane disruption and organelle dysfunction
GCIs in oligodendrocytes are central to MSA pathogenesis:
- Myelin dysfunction: Supporting neuron function is compromised
- Neuronal support loss: Trophic factor provision is impaired
- Network degeneration: Connected neurons degenerate
- Orthostatic hypotension: Severe drop in blood pressure upon standing
- Supine hypertension: Elevated blood pressure when lying down
- Heart rate variability loss: Impaired autonomic responses
- Urinary dysfunction: Incontinence and retention
- Sexual dysfunction: Erectile dysfunction in males
- Sweating abnormalities: Anhidrosis or hyperhidrosis
- Gastroparesis: Delayed gastric emptying
- Constipation: Severe and progressive
- Dysphagia: Difficulty swallowing
- Fludrocortisone: Volume expansion for orthostatic hypotension
- Midodrine: Vasoconstrictor for blood pressure support
- Pyridostigmine: Acetylcholinesterase inhibitor
- Symptomatic treatments: For bladder and GI symptoms
- α-synuclein targeting: Immunotherapies and small molecule inhibitors
- Neuroprotective agents: Targeting specific pathogenic pathways
- Cell-based therapies: Stem cell approaches for autonomic neurons
-
Parkinson's Disease Autonomic Dysfunction
-
Dementia with Lewy Bodies Autonomic Features
-
Pure Autonomic Failure
-
Multiple System Atrophy (MSA)
-
Parkinson's Disease Autonomic Dysfunction
-
Dementia with Lewy Bodies Autonomic Features
-
Pure Autonomic Failure